Algernon Pharmaceuticals Inc (AGNPF)

[shell3]

The FDA has advised that for the toxicology program of the new intravenous Ifenprodil formulation, a single animal 30-day study would be acceptable.

Reformulating a repurposed drug is an important part of the Algernon business model and along with method of use patents, will help to provide protection of its intellectual property rights on a global basis

Does that start the Count Down Today

Selling Rights to different Global areas might bring more than my last projections for NP-120 (Ifenprodil) for idiopathic pulmonary fibrosis (IPF) and chronic cough

Already added Coronavirus for the $1B but down deep

Coronavirus 19 not the last Virus to attack the Lungs

Let’s see Patent Rights — 7 Yrs Rights for Patent or 15 Yrs for Medical

Give it to me DD diggers that have a better Understanding of Medical Patents